Mirati Therapeutics, Inc.: 15-12G filed Feb 2, 2024

Form type

15-12G

Filing date

Feb 2, 2024

Accession number

0001140361-24-005311

Filer

Mirati Therapeutics, Inc. (CIK 1576263)